Emerging Therapies in Schizophrenia

Panelists discuss how innovative treatments—including glutamatergic modulators, muscarinic agonists, and digital interventions—represent the next frontier of schizophrenia care.

Panelists discuss how these new agents aim to address cognitive and negative symptoms often resistant to traditional therapy, filling critical gaps in patient outcomes.

Panelists discuss how combining emerging pharmacologic innovations with technology-driven support could transform disease management over the next decade.